IL152287A0 - Polyamide nucleic acid derivatives, agents and methods for producing the same - Google Patents

Polyamide nucleic acid derivatives, agents and methods for producing the same

Info

Publication number
IL152287A0
IL152287A0 IL15228701A IL15228701A IL152287A0 IL 152287 A0 IL152287 A0 IL 152287A0 IL 15228701 A IL15228701 A IL 15228701A IL 15228701 A IL15228701 A IL 15228701A IL 152287 A0 IL152287 A0 IL 152287A0
Authority
IL
Israel
Prior art keywords
agents
producing
methods
nucleic acid
same
Prior art date
Application number
IL15228701A
Other languages
English (en)
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of IL152287A0 publication Critical patent/IL152287A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyamides (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL15228701A 2000-04-18 2001-04-07 Polyamide nucleic acid derivatives, agents and methods for producing the same IL152287A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10019136A DE10019136A1 (de) 2000-04-18 2000-04-18 Polyamidnukleinsäure-Derivate, Mittel und Verfahren zu ihrer Herstellung
PCT/EP2001/004027 WO2001079249A2 (de) 2000-04-18 2001-04-07 Peptidnukleinsaure-derivate mit negativer ladung, mittel und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
IL152287A0 true IL152287A0 (en) 2003-05-29

Family

ID=7639144

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15228701A IL152287A0 (en) 2000-04-18 2001-04-07 Polyamide nucleic acid derivatives, agents and methods for producing the same
IL152287A IL152287A (en) 2000-04-18 2002-10-14 History of polyamide nucleic acid, preparations and methods for their preparation

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL152287A IL152287A (en) 2000-04-18 2002-10-14 History of polyamide nucleic acid, preparations and methods for their preparation

Country Status (19)

Country Link
US (2) US6777544B2 (no)
EP (1) EP1282639B1 (no)
JP (1) JP5149475B2 (no)
KR (1) KR100815067B1 (no)
AR (1) AR030210A1 (no)
AT (1) ATE302212T1 (no)
AU (2) AU2001246536B2 (no)
BR (1) BR0110111A (no)
CA (1) CA2406168C (no)
DE (2) DE10019136A1 (no)
DK (1) DK1282639T3 (no)
ES (1) ES2246318T3 (no)
IL (2) IL152287A0 (no)
MX (1) MXPA02009738A (no)
NO (1) NO328910B1 (no)
NZ (1) NZ522005A (no)
TW (1) TWI318213B (no)
WO (1) WO2001079249A2 (no)
ZA (1) ZA200208346B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10019135A1 (de) * 2000-04-18 2001-10-31 Aventis Pharma Gmbh Polyamidnukleinsäure-Derivate, Mittel und Verfahren zu ihrer Herstellung
US7270954B1 (en) * 2000-06-30 2007-09-18 Iris Biotechnologies, Inc. Hybridization of target DNA with immobilized nucleic acid analogs
DE10159904A1 (de) * 2001-12-06 2003-07-03 Adnagen Ag Oligonukleotidanordnung, Verfahren zum Nukleotidnachweis sowie Vorrichtung hierfür
US7371852B2 (en) * 2003-01-22 2008-05-13 Serenex, Inc. Alkyl-linked nucleotide compositions
DE102006050091A1 (de) * 2006-10-24 2008-09-11 Ugichem Gesellschaft für Organische Chemie mbH Verfahren zur selektiven Lokalisierung von Wirkstoffen an und in Mitochondrien und entsprechende Wirkstoffe
US20100143937A1 (en) * 2007-05-31 2010-06-10 Sanofi-Aventis ASSAY METHODS FOR IDENTIFYING AGENTS THAT MODIFY THE ACTIVITY OF NAPE-PLD OR Abh4
KR20090098710A (ko) 2008-03-14 2009-09-17 주식회사 씨티아이바이오 세포투과성과 핵산 결합력이 좋은 펩타이드 핵산 유도체
TWI586356B (zh) * 2010-05-14 2017-06-11 可娜公司 藉由抑制ｐａｒ４天然反股轉錄本治療ｐａｒ４相關疾病
US11046999B2 (en) 2015-09-16 2021-06-29 PetaOmics, Inc. Methods and compositions for genomic target enrichment and selective DNA sequencing

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK51092D0 (da) * 1991-05-24 1992-04-15 Ole Buchardt Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf
DE4408531A1 (de) * 1994-03-14 1995-09-28 Hoechst Ag PNA-Synthese unter Verwendung einer gegen schwache Säuren labilen Amino-Schutzgruppe
PT804456E (pt) * 1994-10-06 2003-01-31 Peter Eigil Nielsen Conjugados de acidos nucleicos dos peptidos
DE19508923A1 (de) * 1995-03-13 1996-09-19 Hoechst Ag Phosphonomonoesternukleinsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0739898B1 (de) * 1995-03-13 2001-09-26 Aventis Pharma Deutschland GmbH Phosphonomonoesternnukleinsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19640974A1 (de) 1996-10-04 1998-04-16 Bayer Ag Bausteine für DNA/PNA-Cooligomere
DE19757516A1 (de) * 1997-12-23 1999-06-24 Roche Diagnostics Gmbh Modifizierte Nukleinsäureanaloga
US6043352A (en) * 1998-08-07 2000-03-28 Isis Pharmaceuticals, Inc. 2'-O-Dimethylaminoethyloxyethyl-modified oligonucleotides

Also Published As

Publication number Publication date
AU2001246536B2 (en) 2007-02-15
AU4653601A (en) 2001-10-30
US6777544B2 (en) 2004-08-17
WO2001079249A3 (de) 2002-03-28
MXPA02009738A (es) 2003-03-12
EP1282639A2 (de) 2003-02-12
ATE302212T1 (de) 2005-09-15
NO328910B1 (no) 2010-06-14
TWI318213B (en) 2009-12-11
US20030022172A1 (en) 2003-01-30
US20040265885A1 (en) 2004-12-30
KR20030036167A (ko) 2003-05-09
JP2004502649A (ja) 2004-01-29
NO20024960D0 (no) 2002-10-15
IL152287A (en) 2009-09-22
BR0110111A (pt) 2003-02-11
US7241882B2 (en) 2007-07-10
WO2001079249A2 (de) 2001-10-25
DK1282639T3 (da) 2005-12-12
KR100815067B1 (ko) 2008-03-20
EP1282639B1 (de) 2005-08-17
NZ522005A (en) 2004-12-24
AR030210A1 (es) 2003-08-13
NO20024960L (no) 2002-11-12
CA2406168A1 (en) 2001-10-25
DE50107121D1 (de) 2005-09-22
JP5149475B2 (ja) 2013-02-20
ZA200208346B (en) 2003-10-07
DE10019136A1 (de) 2001-10-31
CA2406168C (en) 2012-01-24
ES2246318T3 (es) 2006-02-16

Similar Documents

Publication Publication Date Title
TWI315741B (en) A-isomaltosyltransferase, process for producing the same and use thereof
WO2002015264A3 (de) Verkapseltes organisch-elektronisches bauteil, verfahren zu seiner herstellung und seine verwendung
IL153508A0 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
PL351148A1 (en) 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
EP1223163A4 (en) PROCESS FOR PRODUCTION OF ACRYLONITRILE, CATALYST USAGE AND METHOD OF PREPARATION THEREOF
IL152288A0 (en) Polyamide nucleic acid derivatives, agents and methods for producing them
EP1223162A4 (en) A METHOD FOR THE PRODUCTION OF ACRYLONITRILE, A CATALYST FOR THIS USE AND A METHOD FOR THE PRODUCTION THEREOF
IL161893A0 (en) 5-Phenylpyrimidines, agents comprising the same, method for production and use thereof
HUP0303034A3 (en) Novel 7-azaindole-derivatives, use thereof as phosphodiesterase 4 inhibitors and method for producing the same
ZA200300743B (en) DDS compound and process for the preparation thereof.
AU4653601A (en) Polyamide nucleic acid derivatives, agents and methods for producing the same
AU2001246536A1 (en) Polyamide nucleic acid derivatives, agents and methods for producing the same
GB2355714B (en) Ammonium 3,5-diaminopicrate
AU2796602A (en) Coniosetin and derivatives thereof, method for producing the same and use thereof
AU2002227966A1 (en) Coniosetin and derivatives thereof, method for producing the same and use thereof
PL358585A1 (en) N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives
EP1273657A4 (en) NOVEL PROTEIN, METHOD FOR PRODUCTION AND USE
AU2001252254A1 (en) 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparationthereof and use thereof
HK1061655A1 (en) Caloporoside derivatives, methods for the production thereof and their use
ZA200303236B (en) Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same.
AU2001254795B2 (en) Polyamide nucleic acid derivatives, agents and methods for producing them
MXPA03004632A (es) Klainetina y sus derivados, metodo para su produccion y su uso.
AU2001254795A1 (en) Polyamide nucleic acid derivatives, agents and methods for producing them
HK1036519A1 (en) Voltage-nonlinear resistance and process for producing the same.
HK1052709A1 (en) Pluraflavins and derivatives thereof, process for their preparation and use thereof pluraflavin.